Contact this trialFirst, we need to learn more about you.
EGFR BATs for Pancreatic Cancer
Recruiting1 awardPhase 1 & 2
Charlottesville, Virginia
This trial will confirm if it is safe to give patients with pancreatic cancer a combination of two drugs, given in 8 infusions over 4 weeks. If Phase Ib is successful, the trial will then test the efficacy of this dose on 22 patients.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service